指南与共识主动脉疾病

升主动脉与主动脉弓的管理:心血管指南之间的异同

Management of Ascending Aorta and Aortic Arch: Similarities and Differences Among Cardiovascular Guidelines.
指南 / 共识 · J Endovasc Ther · 2021-12-07

本文系统检索2009年1月至2020年12月MEDLINE、EMBASE和Cochrane Central Register of Controlled Trials数据库,初检2414篇文献,最终纳入2010至2019年间发表的5篇多学科心血管学会指南,分析其在升主动脉与主动脉弓疾病的定义、诊断、治疗指征与管理方面的推荐异同及证据评估。

要点

  • 多数指南缺乏非A非B型主动脉夹层的定义。
  • 升主动脉直径作为治疗指征的推荐等级与证据水平存在分歧。
  • 当前指南中升主动脉与主动脉弓仍以开放手术为主,仅1个学会强调血管内技术的作用。

核心结论

  • 在当前心血管学会的推荐中,尽管已引入血管内技术,升主动脉与主动脉弓仍属开放手术的范畴。
  • 纳入学会的推荐大多基于专家意见,仅1个学会强调了血管内技术的作用。
  • 指南间的时间异质性和证据水平的不一致性也应予以认识。
  • 需要更多数据以制定更可靠的升主动脉与主动脉弓疾病推荐。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE和Cochrane Central Register of Controlled Trials数据库2009年1月至2020年12月的英文医学文献。
  • 初检识别2414篇文章,排除重复或不适当文章后,最终分析纳入2010至2019年间发表的5篇多学科心血管学会指南。

主要发现

  • 多数指南缺乏非A非B型主动脉夹层的定义。
  • 升主动脉直径作为治疗指征的推荐等级与证据水平存在分歧。
  • 特定病例的治疗指征可个体化,生长速度也可能影响决策。
  • 除1个学会外,当前指南尚未确立血管内技术的作用。
  • 主动脉弓疾病管理中的支持性证据水平仍然有限。

临床怎么用

  • 作者指出,当前心血管学会推荐中升主动脉与主动脉弓仍属开放手术范畴,血管内技术的作用仅由1个学会强调。
  • 作者指出,特定病例的治疗指征可个体化,生长速度也可能影响决策。

局限性

  • 指南间存在时间异质性。
  • 指南间证据水平不一致。
  • 升主动脉与主动脉弓疾病需更多数据以制定更可靠的推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ascending aorta and aortic arch diseases have an increasing interest among cardiovascular specialists regarding diagnosis and management. Innovations in endovascular surgery and evolution of open surgery have extended the indications for treatment in patients previously considered unfit for surgery. The aim of this systematic review of the literature was to present and analyze current cardiovascular guidelines for overlap and differences in their recommendations regarding ascending aorta and aortic arch diseases and the assessment of evidence. METHODS: The English medical literature was searched using the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases from January 2009 to December 2020. Recommendations on selected topics were analyzed, including issues from definitions and diagnosis (imaging and biomarkers) and indications for treatment to management, including surgical techniques, of the most important ascending aorta and aortic arch diseases. RESULTS: The initial search identified 2414 articles. After exclusion of duplicate or inappropriate articles, the final analysis included 5 articles from multidisciplinary, cardiovascular societies published between 2010 and 2019. The definition of non-A-non-B aortic dissection is lacking from most of the guidelines. There is a disagreement regarding the class of recommendation and level of evidence for the diameter of ascending aorta as an indication. The indication for treatment of aortic disease may be individualized in specific cases while the growth rate may also affect the decision making. The role of endovascular techniques has not been established in current guidelines except by 1 society. Supportive evidence level in the management of aortic arch diseases remains limited. CONCLUSION: In current recommendations of cardiovascular societies, the ascending aorta and aortic arch remain a domain of open surgery despite the introduction of endovascular techniques. Recommendations of the included societies are mostly based on expert opinion, and the role of endovascular techniques has been highlighted only from 1 society. The chronological heterogeneity apparent among guidelines and the inconsistency in evidence level should be also acknowledged. More data are needed to develop more solid recommendations for the ascending aorta and aortic arch diseases.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Spanos K, Nana P, von Kodolitsch Y, et al. Management of Ascending Aorta and Aortic Arch: Similarities and Differences Among Cardiovascular Guidelines. J Endovasc Ther. 2021. PMID: 34873944. doi:10.1177/15266028211061271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。